Spurred into action by Pfizer R&D center closing, British leaders seek to
create friendlier environment for life sciences businesses with an optimistic budget proposal
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.